| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.1M | +11.4% | +41.2% |
| R&D Expense | $8.0M | -16.0% | -86.1% |
| SG&A Expense | $15.0M | -9.5% | +15.9% |
| Operating Income | -$11.0M | +26.8% | +82.3% |
| Income Tax | $0 | — | — |
| Net Income | -$10.5M | +28.6% | +82.8% |
| EPS (Basic) | -$0.06 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $85.0M | +143.4% | -20.5% |
| Accounts Receivable | $9.9M | +13.3% | +20.8% |
| Inventory | $25.4M | -0.2% | -6.2% |
| Current Assets | $109.8M | +85.2% | -27.4% |
| Total Assets | $139.2M | +56.1% | -14.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$42.7M | — | — |
| Capital Expenditures | $155K | — | — |
| Investing Cash Flow | -$155K | — | — |
| Financing Cash Flow | $58.5M | — | — |
| Free Cash Flow | -$42.8M | — | — |
| +88.2% |
| EPS (Diluted) | -$0.06 | +50.0% | +88.2% |
| $44.5M |
| +0.1% |
| -43.3% |
| Total Liabilities | $46.1M | -0.6% | -41.5% |
| Stockholders' Equity | $93.1M | +117.5% | +11.9% |